Although all valuations are speculative in nature,I believe Col’s is far more plausible than ValueAdd’s. $2/share is way under value in any way the pie is cut.
What if CF33 as a monotherapy outperforms the combination treatments? What if the OV completely disrupts existing treatments altogether? What if it is used as a vaccine? How long can the OV remain viable in the body? Could ppl require an annual / regular vaccine? How will potential combo treatments be split? 50/50, 80/20? The possibilities are vast. If CF33 reaches the heights we are all hoping, every government across the globe will want a piece of it. It will change humanity. Productivity, healthcare costs, quality of life, quality of relationships, no side effects.. the implications are mind-boggling.
In my eyes this company could well be a 100-bagger. I will not be selling at $2/share
IMU Target $2.00 - Not Ramping !!!, page-6
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.4¢ | 7.0¢ | $1.222M | 16.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 942474 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 200000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.000 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.3¢ | 7.0¢ | 6985767 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| IMU (ASX) Chart |